AVNS: Avanos Medical, Inc.
About
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Current Value
$17.681 Year Return
Current Value
$17.681 Year Return
Key Details
Market Cap
$818.03M
P/E Ratio
52.77
1Y Stock Return
-16.00%
1Y Revenue Growth
-9.12%
Dividend Yield
0.00%
Price to Book
0.7
Strategies that include AVNS
Stock's related to AVNS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DAN | 55.70% | $1.14B | -38.75% | 5.12% |
| OPCH | 55.40% | $3.71B | -27.12% | 0.00% |
| KFRC | 54.99% | $1.10B | -8.71% | 0.66% |
| GIC | 51.65% | $1.04B | -25.63% | 3.67% |
| BLKB | 49.20% | $4.23B | +12.05% | 0.00% |
| AXTA | 48.94% | $8.47B | +25.51% | 0.00% |
| OPK | 48.75% | $1.11B | +7.64% | 0.00% |
| CPF | 48.68% | $832.77M | +76.33% | 3.35% |
| ATNI | 48.27% | $290.80M | -37.65% | 4.95% |
| RDUS | 47.92% | $492.65M | -31.07% | 4.30% |
| ARR | 47.37% | $1.05B | +8.10% | 16.27% |
| CLH | 47.21% | $13.30B | +50.38% | 0.00% |
| SMG | 46.59% | $4.24B | +35.01% | 3.52% |
| CHE | 46.11% | $8.20B | -5.60% | 0.33% |
| ILPT | 45.82% | $253.33M | +31.62% | 1.05% |
| YORW | 45.76% | $514.17M | -3.87% | 2.37% |
| MATW | 45.11% | $731.28M | -31.68% | 4.06% |
| SUNS | 44.92% | $105.89M | +35.31% | 1.37% |
| DX | 44.80% | $991.29M | +9.75% | 12.54% |
| UVSP | 44.35% | $891.91M | +64.40% | 2.76% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| OKLO | 0.02% | $2.66B | +111.04% | 0.00% |
| ANF | 0.10% | $7.28B | +92.60% | 0.00% |
| HIHO | -0.15% | $8.63M | 0.00% | 6.12% |
| UIS | 0.16% | $511.20M | +51.33% | 0.00% |
| EL | -0.25% | $23.26B | -46.08% | 4.10% |
| ALL | 0.25% | $52.06B | +45.67% | 1.85% |
| QS | -0.27% | $2.54B | -13.31% | 0.00% |
| IMNN | -0.30% | $10.02M | -22.89% | 0.00% |
| CATX | 0.39% | $458.24M | +162.59% | 0.00% |
| NXTC | 0.41% | $36.69M | +6.50% | 0.00% |
| BACK | 0.46% | $1.76M | -32.90% | 0.00% |
| CPSH | 0.53% | $20.70M | -40.13% | 0.00% |
| NFLX | 0.56% | $372.45B | +83.46% | 0.00% |
| NLOP | 0.64% | $458.04M | +94.60% | 0.00% |
| VHC | 0.67% | $19.06M | -38.36% | 0.00% |
| ASTE | 0.80% | $820.86M | +13.24% | 1.45% |
| TAL | 0.84% | $4.54B | +2.16% | 0.00% |
| BNED | 0.84% | $277.22M | -91.94% | 0.00% |
| COST | -0.84% | $412.13B | +62.81% | 0.49% |
| GAN | 0.85% | $83.39M | +21.19% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RDDT | -20.68% | $24.08B | +303.41% | 0.00% |
| UNM | -16.47% | $13.16B | +69.20% | 2.16% |
| SW | -15.71% | $13.78B | +15.02% | 1.14% |
| PAYC | -13.89% | $12.12B | +21.78% | 0.69% |
| GRMN | -13.43% | $39.82B | +73.79% | 1.43% |
| NEUE | -13.37% | $40.93M | -34.13% | 0.00% |
| MCK | -10.87% | $78.15B | +35.51% | 0.42% |
| XBIO | -10.63% | $6.01M | +21.36% | 0.00% |
| IBKR | -10.25% | $20.20B | +131.83% | 0.37% |
| BTCT | -10.11% | $42.61M | +353.33% | 0.00% |
| TPST | -9.81% | $37.75M | -77.59% | 0.00% |
| HUSA | -9.45% | $16.69M | -11.56% | 0.00% |
| TW | -8.46% | $28.66B | +42.39% | 0.29% |
| MNR | -7.42% | $1.66B | -10.71% | 15.90% |
| DYN | -7.42% | $3.02B | +182.40% | 0.00% |
| NRDS | -7.32% | $984.08M | +21.93% | 0.00% |
| LLY | -7.24% | $692.74B | +23.14% | 0.71% |
| CME | -7.18% | $82.76B | +9.21% | 1.98% |
| RBRK | -7.11% | $8.03B | +38.16% | 0.00% |
| TRVG | -7.09% | $37.05M | -37.92% | 0.00% |
ETF's related to AVNS
News
Yahoo
Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m. ET.
Finnhub
ALPHARETTA - Avanos Medical, Inc. announced today that the Centers for Medicare and Medicaid Services has issued its final Medicare Hospital Outpatient Prospective Payment System and Medicare...
Yahoo
Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025. This rule, effective Jan. 1, 2025, implements the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act that mandates separate Medicare payment for qualifying non-opioid drugs and devices.
Finnhub
ALPHARETTA - Avanos Medical, Inc. today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues., Nov. 12 at...
Yahoo
The stock was sluggish on the back of Avanos Medical, Inc.'s ( NYSE:AVNS ) recent earnings report. Along with the solid...
Finnhub
ALPHARETTA - Avanos Medical, Inc. today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.